top of page

RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL

Product details

Registration number: SIN17184P

Classification: Prescription Only

Active ingredients: Risperidone

Strength: 37.5mg/vial

Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE

Route: INTRAMUSCULAR

Registrant: LUYE PHARMA (SINGAPORE) PTE. LTD.

ATC code: N05AX08

HSA approval date: 20 February 2025

Manufacturer(s):

  • Shandong Luye Pharmaceutical Co., Ltd.
  • Shandong Luye Pharmaceutical Co., Ltd. (Diluent)

Manufacturing country/countries: CHINA

What are the HSA registration number and classification for RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17184P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Risperidone

Strength: 37.5mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Registrant: LUYE PHARMA (SINGAPORE) PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Shandong Luye Pharmaceutical Co., Ltd.
  • Shandong Luye Pharmaceutical Co., Ltd. (Diluent)

Manufacturing country/countries: CHINA

Source for this answer

Where can I look up RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17184P or the exact product name RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL. The general register link does not preselect this product.

Source for this answer

What are the source dates for this RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 37.5MG/VIAL record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17184P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page